ソフォスブビルの世界市場2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global Sofosbuvir (CAS 1190307-88-0) Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：MRC2012A8800 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学、材料

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、ソフォスブビルの世界市場を広く調査・分析し、今後の市場展望をまとめております。ソフォスブビルの種類別市場規模（98％純度以上、98％純度以下）、用途別市場規模（400mg錠、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Teva Pharmaceutical Industries Ltd、Beijing Kawin Technology Share-holding Co、DEAFARMA、DONG BANG FUTURE TECH & LIFE CO., LTD、SMS Pharmaceuticals Limited、NIFTY LABS PVT LTD、Hangzhou Longshine Bio-Tech Co、Haoyuan Chemexpress Co.Ltd、Anhui HaiKang Pharmaceutical Co. Ltd、Manus Aktteva Biopharma LLP、Tecoland、Sinobright Pharmaceutical Company Limited、 ・地域別グローバル市場分析 2015年-2020年 ・ソフォスブビルの北米市場（アメリカ、カナダ、メキシコ） ・ソフォスブビルのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ソフォスブビルのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ソフォスブビルの南米市場（ブラジル、アルゼンチン） ・ソフォスブビルの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：98％純度以上、98％純度以下 ・用途別分析：400mg錠、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Sofosbuvir (CAS 1190307-88-0) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Sofosbuvir (CAS 1190307-88-0) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Sofosbuvir (CAS 1190307-88-0) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Sofosbuvir (CAS 1190307-88-0) market has been segmented into
AbovE98% Purity
Below 98% Purity

By Application, Sofosbuvir (CAS 1190307-88-0) has been segmented into:
400mg Tablets
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sofosbuvir (CAS 1190307-88-0) market presented in the report. This section sheds light on the sales growth of different regional and country-level Sofosbuvir (CAS 1190307-88-0) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sofosbuvir (CAS 1190307-88-0) market.

The report offers in-depth assessment of the growth and other aspects of the Sofosbuvir (CAS 1190307-88-0) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Sofosbuvir (CAS 1190307-88-0) Market Share Analysis
Sofosbuvir (CAS 1190307-88-0) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sofosbuvir (CAS 1190307-88-0) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sofosbuvir (CAS 1190307-88-0) sales, revenue and market share for each player covered in this report.

The major players covered in Sofosbuvir (CAS 1190307-88-0) are:
Teva Pharmaceutical Industries Ltd
Beijing Kawin Technology Share-holding Co
DEAFARMA
DONG BANG FUTURE TECH & LIFE CO., LTD
SMS Pharmaceuticals Limited
NIFTY LABS PVT LTD
Hangzhou Longshine Bio-Tech Co
Haoyuan Chemexpress Co.Ltd
Anhui HaiKang Pharmaceutical Co. Ltd
Manus Aktteva Biopharma LLP
Tecoland
Sinobright Pharmaceutical Company Limited

Among other players domestic and global, Sofosbuvir (CAS 1190307-88-0) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sofosbuvir (CAS 1190307-88-0) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sofosbuvir (CAS 1190307-88-0), with price, sales, revenue and global market share of Sofosbuvir (CAS 1190307-88-0) in 2018 and 2019.
Chapter 3, the Sofosbuvir (CAS 1190307-88-0) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sofosbuvir (CAS 1190307-88-0) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Sofosbuvir (CAS 1190307-88-0) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Sofosbuvir (CAS 1190307-88-0) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Sofosbuvir (CAS 1190307-88-0) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 AbovE98% Purity
1.2.3 Below 98% Purity
1.3 Market Analysis by Application
1.3.1 Overview: Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 400mg Tablets
1.3.3 Others
1.4 Overview of Global Sofosbuvir (CAS 1190307-88-0) Market
1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva Pharmaceutical Industries Ltd
2.1.1 Teva Pharmaceutical Industries Ltd Details
2.1.2 Teva Pharmaceutical Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva Pharmaceutical Industries Ltd SWOT Analysis
2.1.4 Teva Pharmaceutical Industries Ltd Product and Services
2.1.5 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Beijing Kawin Technology Share-holding Co
2.2.1 Beijing Kawin Technology Share-holding Co Details
2.2.2 Beijing Kawin Technology Share-holding Co Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Beijing Kawin Technology Share-holding Co SWOT Analysis
2.2.4 Beijing Kawin Technology Share-holding Co Product and Services
2.2.5 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 DEAFARMA
2.3.1 DEAFARMA Details
2.3.2 DEAFARMA Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 DEAFARMA SWOT Analysis
2.3.4 DEAFARMA Product and Services
2.3.5 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 DONG BANG FUTURE TECH & LIFE CO., LTD
2.4.1 DONG BANG FUTURE TECH & LIFE CO., LTD Details
2.4.2 DONG BANG FUTURE TECH & LIFE CO., LTD Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 DONG BANG FUTURE TECH & LIFE CO., LTD SWOT Analysis
2.4.4 DONG BANG FUTURE TECH & LIFE CO., LTD Product and Services
2.4.5 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 SMS Pharmaceuticals Limited
2.5.1 SMS Pharmaceuticals Limited Details
2.5.2 SMS Pharmaceuticals Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 SMS Pharmaceuticals Limited SWOT Analysis
2.5.4 SMS Pharmaceuticals Limited Product and Services
2.5.5 SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 NIFTY LABS PVT LTD
2.6.1 NIFTY LABS PVT LTD Details
2.6.2 NIFTY LABS PVT LTD Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 NIFTY LABS PVT LTD SWOT Analysis
2.6.4 NIFTY LABS PVT LTD Product and Services
2.6.5 NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hangzhou Longshine Bio-Tech Co
2.7.1 Hangzhou Longshine Bio-Tech Co Details
2.7.2 Hangzhou Longshine Bio-Tech Co Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hangzhou Longshine Bio-Tech Co SWOT Analysis
2.7.4 Hangzhou Longshine Bio-Tech Co Product and Services
2.7.5 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Haoyuan Chemexpress Co.Ltd
2.8.1 Haoyuan Chemexpress Co.Ltd Details
2.8.2 Haoyuan Chemexpress Co.Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Haoyuan Chemexpress Co.Ltd SWOT Analysis
2.8.4 Haoyuan Chemexpress Co.Ltd Product and Services
2.8.5 Haoyuan Chemexpress Co.Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Anhui HaiKang Pharmaceutical Co. Ltd
2.9.1 Anhui HaiKang Pharmaceutical Co. Ltd Details
2.9.2 Anhui HaiKang Pharmaceutical Co. Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Anhui HaiKang Pharmaceutical Co. Ltd SWOT Analysis
2.9.4 Anhui HaiKang Pharmaceutical Co. Ltd Product and Services
2.9.5 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Manus Aktteva Biopharma LLP
2.10.1 Manus Aktteva Biopharma LLP Details
2.10.2 Manus Aktteva Biopharma LLP Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Manus Aktteva Biopharma LLP SWOT Analysis
2.10.4 Manus Aktteva Biopharma LLP Product and Services
2.10.5 Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Tecoland
2.11.1 Tecoland Details
2.11.2 Tecoland Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Tecoland SWOT Analysis
2.11.4 Tecoland Product and Services
2.11.5 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sinobright Pharmaceutical Company Limited
2.12.1 Sinobright Pharmaceutical Company Limited Details
2.12.2 Sinobright Pharmaceutical Company Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sinobright Pharmaceutical Company Limited SWOT Analysis
2.12.4 Sinobright Pharmaceutical Company Limited Product and Services
2.12.5 Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Sofosbuvir (CAS 1190307-88-0) Manufacturer Market Share in 2019
3.3.2 Top 6 Sofosbuvir (CAS 1190307-88-0) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Regions
4.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Regions (2015-2020)
4.2 North America Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
4.3 Europe Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
4.5 South America Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Country
5.1.1 North America Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Country (2015-2020)
5.1.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Country (2015-2020)
5.2 United States Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
5.3 Canada Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
5.4 Mexico Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Country
6.1.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Country (2015-2020)
6.2 Germany Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
6.3 UK Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
6.4 France Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
6.5 Russia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
6.6 Italy Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Regions (2015-2020)
7.2 China Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
7.3 Japan Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
7.4 Korea Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
7.5 India Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
7.7 Australia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Country
8.1.1 South America Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Country (2015-2020)
8.1.2 South America Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
8.3 Argentina Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
9.3 Turkey Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
9.4 Egypt Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
9.5 South Africa Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Type (2015-2020)
10.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Type (2015-2020)
10.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2015-2020)
11 Global Sofosbuvir (CAS 1190307-88-0) Market Segment by Application
11.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2015-2020)
11.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2015-2020)
11.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Growth Rate (2021-2025)
12.2 Sofosbuvir (CAS 1190307-88-0) Market Forecast by Regions (2021-2025)
12.2.1 North America Sofosbuvir (CAS 1190307-88-0) Market Forecast (2021-2025)
12.2.2 Europe Sofosbuvir (CAS 1190307-88-0) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Market Forecast (2021-2025)
12.2.4 South America Sofosbuvir (CAS 1190307-88-0) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Market Forecast (2021-2025)
12.3 Sofosbuvir (CAS 1190307-88-0) Market Forecast by Type (2021-2025)
12.3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Type (2021-2025)
12.3.2 Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Type (2021-2025)
12.4 Sofosbuvir (CAS 1190307-88-0) Market Forecast by Application (2021-2025)
12.4.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Application (2021-2025)
12.4.2 Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Sofosbuvir (CAS 1190307-88-0) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sofosbuvir (CAS 1190307-88-0) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sofosbuvir (CAS 1190307-88-0) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Major Business
Table 9. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 10. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 11. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 12. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Beijing Kawin Technology Share-holding Co Basic Information, Manufacturing Base and Competitors
Table 14. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Major Business
Table 15. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 16. Beijing Kawin Technology Share-holding Co SWOT Analysis
Table 17. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 18. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. DEAFARMA Basic Information, Manufacturing Base and Competitors
Table 20. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Major Business
Table 21. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 22. DEAFARMA SWOT Analysis
Table 23. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 24. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. DONG BANG FUTURE TECH & LIFE CO., LTD Basic Information, Manufacturing Base and Competitors
Table 26. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Major Business
Table 27. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 28. DONG BANG FUTURE TECH & LIFE CO., LTD SWOT Analysis
Table 29. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 30. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. SMS Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table 32. SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Major Business
Table 33. SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 34. SMS Pharmaceuticals Limited SWOT Analysis
Table 35. SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 36. SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. NIFTY LABS PVT LTD Basic Information, Manufacturing Base and Competitors
Table 38. NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Major Business
Table 39. NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 40. NIFTY LABS PVT LTD SWOT Analysis
Table 41. NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 42. NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Hangzhou Longshine Bio-Tech Co Basic Information, Manufacturing Base and Competitors
Table 44. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Major Business
Table 45. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 46. Hangzhou Longshine Bio-Tech Co SWOT Analysis
Table 47. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 48. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Haoyuan Chemexpress Co.Ltd Basic Information, Manufacturing Base and Competitors
Table 50. Haoyuan Chemexpress Co.Ltd Sofosbuvir (CAS 1190307-88-0) Major Business
Table 51. Haoyuan Chemexpress Co.Ltd Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 52. Haoyuan Chemexpress Co.Ltd SWOT Analysis
Table 53. Haoyuan Chemexpress Co.Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 54. Haoyuan Chemexpress Co.Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Anhui HaiKang Pharmaceutical Co. Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Major Business
Table 57. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 58. Anhui HaiKang Pharmaceutical Co. Ltd SWOT Analysis
Table 59. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 60. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Manus Aktteva Biopharma LLP Basic Information, Manufacturing Base and Competitors
Table 62. Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Major Business
Table 63. Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 64. Manus Aktteva Biopharma LLP SWOT Analysis
Table 65. Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 66. Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Tecoland Basic Information, Manufacturing Base and Competitors
Table 68. Tecoland Sofosbuvir (CAS 1190307-88-0) Major Business
Table 69. Tecoland Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 70. Tecoland SWOT Analysis
Table 71. Tecoland Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 72. Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Sinobright Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 74. Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Major Business
Table 75. Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Total Revenue (USD Million) (2017-2018)
Table 76. Sinobright Pharmaceutical Company Limited SWOT Analysis
Table 77. Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Product and Services
Table 78. Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturer (2018-2019) (MT)
Table 80. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Sofosbuvir (CAS 1190307-88-0) Sales by Regions (2015-2020) (MT)
Table 82. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Regions (2015-2020)
Table 83. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Sofosbuvir (CAS 1190307-88-0) Sales by Countries (2015-2020) (MT)
Table 85. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries (2015-2020)
Table 86. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries (2015-2020)
Table 88. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Countries (2015-2020) (MT)
Table 89. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries (2015-2020)
Table 90. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Regions (2015-2020) (MT)
Table 92. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Sofosbuvir (CAS 1190307-88-0) Sales by Countries (2015-2020) (MT)
Table 95. South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries (2015-2020)
Table 96. South America Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Countries (2015-2020) (MT)
Table 99. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries (2015-2020)
Table 102. Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2015-2020) (MT)
Table 103. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Type (2015-2020)
Table 104. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2015-2020) (USD Million)
Table 105. Global Sofosbuvir (CAS 1190307-88-0) Revenue Share by Type (2015-2020)
Table 106. Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2015-2020) (MT)
Table 107. Global Sofosbuvir (CAS 1190307-88-0) Sales Share by Application (2015-2020)
Table 108. Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Regions (2021-2025) (MT)
Table 109. Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Regions (2021-2025)
Table 110. Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Type (2021-2025) (MT)
Table 111. Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Type (2021-2025)
Table 112. Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Application (2021-2025)
Table 113. Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Sofosbuvir (CAS 1190307-88-0) Picture
Figure 2. Global Sales Market Share of Sofosbuvir (CAS 1190307-88-0) by Type in 2019
Figure 3. AbovE98% Purity Picture
Figure 4. Below 98% Purity Picture
Figure 5. Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application in 2018
Figure 6. 400mg Tablets Picture
Figure 7. Others Picture
Figure 8. Global Sofosbuvir (CAS 1190307-88-0) Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Sofosbuvir (CAS 1190307-88-0) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Manufacturer in 2019
Figure 29. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Sofosbuvir (CAS 1190307-88-0) Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Sofosbuvir (CAS 1190307-88-0) Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 34. Global Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Regions (2015-2020)
Figure 36. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Regions in 2018
Figure 37. North America Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
Figure 38. Europe Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
Figure 40. South America Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020)
Figure 42. North America Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries (2015-2020)
Figure 44. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries in 2018
Figure 45. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries in 2018
Figure 47. United States Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 48. Canada Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 49. Mexico Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 50. Europe Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries in 2019
Figure 53. Germany Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 54. UK Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 55. France Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 56. Russia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 57. Italy Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 58. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Regions 2019
Figure 61. China Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 62. Japan Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 63. Korea Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 64. India Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 65. Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 66. South America Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries in 2019
Figure 68. South America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries in 2019
Figure 69. Brazil Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 70. Argentina Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 71. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 76. Egypt Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 77. Turkey Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 78. South Africa Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2015-2020) (MT)
Figure 79. Global Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2021-2025) (MT)
Figure 80. Global Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Sofosbuvir (CAS 1190307-88-0) Market Forecast (2021-2025) (MT)
Figure 82. Europe Sales Sofosbuvir (CAS 1190307-88-0) Market Forecast (2021-2025) (MT)
Figure 83. Asia-Pacific Sales Sofosbuvir (CAS 1190307-88-0) Market Forecast (2021-2025) (MT)
Figure 84. South America Sales Sofosbuvir (CAS 1190307-88-0) Market Forecast (2021-2025) (MT)
Figure 85. Middle East & Africa Sales Sofosbuvir (CAS 1190307-88-0) Market Forecast (2021-2025) (MT)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel

---